Microbot Medical Inc. (MBOT) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Microbot Medical Inc. on March 17, 2026. The filing serves as a Regulation FD disclosure regarding an upcoming investor event and the release of updated presentation materials.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is an event notification and does not contain financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this document. The filing solely announces the Company's participation in an external conference.
Guidance, Outlook, and Management Commentary
- Upcoming Event: The Company will participate in the Roth Annual Growth Conference held March 22-24, 2026, in Laguna Niguel, CA.
- Management Presentation: Harel Gadot, CEO, President, and Chairman, will present via a live fireside Q&A discussion on Monday, March 23, 2026, at 4:00 pm PT.
- Access: A live webcast will be available via the "Events" section of the Company's website (www.microbotmedical.com).
- Materials: Updated presentation materials have been released and are available under "IR Resources" on the Company's website. The Company explicitly states it is not undertaking to update these materials.
Key Facts for Investor Verification
- Verify the date and time of the Roth Annual Growth Conference presentation (March 23, 2026, 4:00 pm PT).
- Access the updated presentation materials (Exhibit 99.2) via the Company's investor relations website.
- Note that the information in this Item 7.01 and its exhibits is furnished, not filed, and is not subject to Section 18 liabilities of the Exchange Act.